Shares of Transcat, Inc. (NASDAQ:TRNS – Get Free Report) have been assigned an average rating of “Moderate Buy” from the seven research firms that are currently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation, two have issued a buy recommendation and two have given a strong buy recommendation to the company. The average 1-year target price among brokers that have covered the stock in the last year is $105.3333.
A number of research firms recently weighed in on TRNS. Northland Securities set a $95.00 target price on shares of Transcat in a report on Thursday, October 23rd. Weiss Ratings reissued a “sell (d+)” rating on shares of Transcat in a research note on Monday, December 29th. Northland Capmk upgraded Transcat from a “hold” rating to a “strong-buy” rating in a report on Thursday, October 23rd. Finally, Zacks Research upgraded Transcat from a “hold” rating to a “strong-buy” rating in a report on Tuesday, October 7th.
Check Out Our Latest Analysis on Transcat
Hedge Funds Weigh In On Transcat
Transcat Price Performance
TRNS stock opened at $62.54 on Thursday. Transcat has a 12-month low of $50.23 and a 12-month high of $111.29. The company has a quick ratio of 2.06, a current ratio of 2.43 and a debt-to-equity ratio of 0.38. The company’s fifty day simple moving average is $58.20 and its 200 day simple moving average is $71.79. The firm has a market cap of $583.50 million, a price-to-earnings ratio of 51.26 and a beta of 0.78.
Transcat (NASDAQ:TRNS – Get Free Report) last released its earnings results on Monday, November 3rd. The scientific and technical instruments company reported $0.44 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.46 by ($0.02). Transcat had a net margin of 3.75% and a return on equity of 6.81%. The company had revenue of $82.27 million for the quarter, compared to analyst estimates of $79.51 million. On average, analysts expect that Transcat will post 2.3 earnings per share for the current year.
About Transcat
Transcat, Inc (NASDAQ: TRNS) is a leading provider of calibration, laboratory, and metrology services in North America. Founded in 1964 and headquartered in Ronkonkoma, New York, the company specializes in ensuring the accuracy and compliance of measurement instruments across a wide range of industries. Transcat operates a network of ISO/IEC 17025–accredited laboratories and offers on-site field calibration, instrument repair, and preventive maintenance services.
In addition to its calibration services, Transcat distributes precision instrumentation and related software solutions from top manufacturers.
Featured Stories
- Five stocks we like better than Transcat
- A month before the crash
- How a Family Trust May Be Able To Help Preserve Your Wealth
- BNZI: BNZI Surges Ahead as AI Marketing Fuels Record Revenue
- You Still Think Silver’s a Joke? Watch What Happens Next.
- A U.S. “birthright” claim worth trillions – activated quietly
Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.
